Clinical Trials Logo

Arrhythmias, Cardiac clinical trials

View clinical trials related to Arrhythmias, Cardiac.

Filter by:

NCT ID: NCT05694572 Recruiting - Heart Failure Clinical Trials

Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices

PIANO
Start date: October 30, 2023
Phase:
Study type: Observational [Patient Registry]

The primary objective of the study is to assess the chronic safety of MicroPort CRM market-released systems.

NCT ID: NCT05694273 Not yet recruiting - Arrhythmia Clinical Trials

Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation

CENTRAL
Start date: January 15, 2025
Phase:
Study type: Observational

This study aims to evaluate the incidence, clinical characteristics, and short-term prognosis of acute cerebrovascular events occurring in-hospital in patients with arrhythmias following catheter ablation. The goal is to provide evidence supporting the improvement of patient quality of life and reduction of in-hospital acute cerebrovascular complications in patients with post-ablation arrhythmias. This will also contribute to the evidence-based clinical management of such patients.

NCT ID: NCT05676398 Recruiting - Bradycardia Clinical Trials

Cardiac Arrhythmias at Extreme Altitude

SUMMIT
Start date: January 1, 2023
Phase:
Study type: Observational

Background: Exposure to high altitudes has been associated with an increased risk of cardiac arrhythmias in healthy subjects and an increased risk of sudden cardiac death. Aim: The aim of the present study is to evaluate the risk and the incidence of cardiac arrhythmias at extreme altitude. Methods: This is a prospective cohort study of healthy volunteers determined to climb Mount Everest. Subjects will be evaluated for eligibility by electrocardiography and echocardiography. All study participants will undergo ambulatory rhythm monitoring in their home environment within 12 weeks of the climb. Subsequently, ambulatory rhythm monitoring will be repeated during the ascent from basecamp to the summit of Mount Everest. The primary endpoint will be the composite of supraventricular and ventricular tachyarrhythmias, and bradyarrhythmias.

NCT ID: NCT05668377 Recruiting - Clinical trials for Arrhythmias, Cardiac

Automated Diagnostic Performance of Smartwatch ECG for Arrhythmia Detection Using the PulseAI Neural Network.

Start date: January 1, 2023
Phase:
Study type: Observational

The study is to evaluate the performance of the PulseAI neural network technology at interpreting ECG data recorded using a single-lead Smartwatch (Apple Watch).

NCT ID: NCT05662293 Recruiting - Cardiomyopathy Clinical Trials

Characterization of Arrhythmia-induced Cardiomyopathy

Start date: June 10, 2021
Phase:
Study type: Observational

The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.

NCT ID: NCT05645978 Recruiting - Obesity Clinical Trials

Association of Obesity and Cardiovascular Outcomes in Patients With Pacemaker

Paradox
Start date: July 1, 2022
Phase:
Study type: Observational

In this study, the investigators evaluated the association between various measures of adiposity [BMI and waist circumference (WC)] and clinical outcomes in Asian patients who underwent pacemaker insertion, using a nationwide population based cohort.

NCT ID: NCT05645965 Recruiting - Obesity Clinical Trials

Association of Obesity and Cardiovascular Outcomes in Patients With Implantable Cardioverter-defibrillator (ICD)

Paradox
Start date: July 1, 2022
Phase:
Study type: Observational

In this study, the investigators evaluated the association between various measures of adiposity [BMI and waist circumference (WC)] and clinical outcomes in Asian patients who underwent Implantable Cardioverter-defibrillator (ICD) insertion, using a nationwide population based cohort.

NCT ID: NCT05643235 Recruiting - Atrial Fibrillation Clinical Trials

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This study will enroll patients initiating Bruton Tyrosine Kinase (BTK) inhibitors without history of documented arrhythmia while on therapy using the Medtronic LINQ-2 insertable cardiac monitor (ILR). The incidence of new onset atrial fibrillation (AF) and other arrhythmia will be determined. Actions taken in response to device detected arrhythmia will be recorded.

NCT ID: NCT05640323 Completed - Healthy Clinical Trials

Prospective Study to Validate the Clinical Accuracy of the Norbert Device to Measure Pulse Rate

Start date: April 26, 2023
Phase:
Study type: Observational

The study will evaluate the mean average error (MAE) of measuring pulse rate using the Norbert Device (ND) as compared to a reference heart rate measured using an electrocardiogram (ECG).

NCT ID: NCT05636956 Recruiting - Heart Failure Clinical Trials

Education and Counseling Program on Patients With CIEDs and Low HL

Start date: June 26, 2022
Phase: N/A
Study type: Interventional

The goal of this RCT (randomized controlled trial) is to investigate the effect of education and counseling program that researches developed on patients with cardiac implantable electronic devices (CIEDs) and low health literacy. The main questions are; Is there a difference between the health literacy scores of intervention and control groups after education and counseling program? Is there a difference between the CIEDs knowledge scores of intervention and control groups after education and counseling program? Is there a difference between the daily life activity scores of intervention and control groups after education and counseling program? Researches offer an education and counseling program about living with CIEDs to patients that having CIEDs for the first time. Participants answers questions in Health Literacy Survey European Questionnaire 16, cardiac implantable electronic devices knowledge scale (researches developed) and Duke Activity Index before education and counseling program, at first month, third month and sixth month after implantation. Reseraches compare scores between intervention and control groups, also different times in same groups.